Posterior Reversible Encephalopathy Syndrome in ALL
Investigators from Soochow University, Suzhou, China, studied the possible pathogenetic mechanisms and treatment of posterior reversible encephalopathy syndrome (PRES) observed in 11 cases of pediatric acute lymphoblastic leukemia (ALL) after induction chemotherapy.
Main Author: | J. Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2015-07-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/106 |
Similar Items
-
Post-partum posterior reversible encephalopathy syndrome
by: B. V. Triveni, et al.
Published: (2014-01-01) -
Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome
by: Tai-Heng Chen, et al.
Published: (2020-09-01) -
Posterior Reversible Encephalopathy Syndrome and Azathioprine
by: Sara Pinto Teixeira Vilas-Boas, et al.
Published: (2019-01-01) -
Posterior Reversible Encephalopathy Syndrome in a Patient with Post Streptococcal Glomerulonephritis: A Case Report
by: Deependra Mandal, et al.
Published: (2020-12-01) -
Posterior reversible encephalopathy syndrome
by: Neha Sivaguru, et al.
Published: (2018-01-01)